Gerson Lehrman Group - Intelligently Connecting Institutions and Expertise.

Expert Insights on Pharmaceutical Industry

The Pharmaceutical Industry is the business sector typically encompassing the production and use of small molecule drugs derived from chemical sources. These substances are aimed at treating, curing, preventing, or recognizing disease.

Gerson Lehrman Group Council Members are available to discuss Pharmaceutical Industry via phone consultations, live meetings, surveys, and other custom GLG products and services.

Find, engage, and manageSM experts today through the GLG platform

Featured Council Members

GLG Council Members are leading experts including academics, scientists, and industry specialists

Gregory Glover, Partner, Pharmaceutical Law Group PC

Gregory GloverWhat is a GLG Educator?|GLG Educators have qualified for GLG Member Programs and are therefore eligible to participate in ongoing in-depth consulting projects with GLG clients.

PartnerPharmaceutical Law Group PC

Kuldeepak Sharma, President/Pharmaceutical Consultant, Dr. Kuldeepak Sharma

Kuldeepak SharmaWhat is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

President/Pharmaceutical ConsultantDr. Kuldeepak Sharma

Anthony Guacci, President, MaxR LLC

Anthony GuacciWhat is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

PresidentMaxR LLC

Nailesh Bhatt, Managing Director, PROXIMARE INC

Nailesh BhattWhat is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

Managing DirectorPROXIMARE INC

Mark Capriani, President and Chief Executive Officer, ACIES HEALTH INC

Mark CaprianiWhat is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

President and Chief Executive OfficerACIES HEALTH INC

Browse all 424 Leading Experts

Study Groups

Study groups are populations of experts knowledgeable on specific sub-topics within a broader industry

Study Group Name No. Members
Pharmaceutical and Biotechnology Experts: Lawyers (EU) 79
Marketing Experts: Pharmaceutical Companies (US) 36
Pharmaceutical & Biotechnology Experts (Mexico and South America) 173
Pharmaceutical and Biotechnology Experts: Lawyers (US) 57
Pharmaceutical Regulation and FDA Experts: Lawyers 48

Browse all 974 Study Groups

Recent Live Meetings

Interactive roundtables, private visits, and small scale seminars are types of GLG Live Meetings

May 22, 2009 | Webcast

GLG Webcast: Consolidation Trends - China Pharma on May 22, 2009 at 7:30AM ET

Browse all 278 Live Meetings

Recent News Analyses

News analyses are expert commentaries on current events, written by Council Members who are available for follow up consultations

Sandoz’ Generic Drug Push in Japan: Good Timing; Interesting Challenges

October 7, 2009

GLG Expert Contributor

India is a good clinical trial destination with new CROs in future

September 27, 2009

GLG Expert Contributor

Electronic Health Record Data will be an Industry Gold Mine

October 2, 2009

GLG Expert Contributor

Browse all 7849 GLG News Analyses

Contact Gerson Lehrman Group to engage a Pharmaceutical Industry expert